Africa
New malaria target identified with potential to prevent, block, and treat multiple stages of the malaria life cycle
Novartis scientists have discovered a new drug target for treating malaria. The discovery, which is published online in the journal Nature,[2] identifies phosphatidylinositol-4 kinase (PfPI4K) as the target of the imidazopyrazines, a novel experimental antimalarial […]